Polar Capital Holdings Plc Increases Stock Position in Addus HomeCare Co. (NASDAQ:ADUS)

Polar Capital Holdings Plc increased its position in Addus HomeCare Co. (NASDAQ:ADUS) by 0.6% in the fourth quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The fund owned 29,349 shares of the company’s stock after buying an additional 185 shares during the period. Polar Capital Holdings Plc owned about 0.16% of Addus HomeCare worth $3,679,000 as of its most recent SEC filing.

Other institutional investors and hedge funds have also recently bought and sold shares of the company. Natixis boosted its stake in shares of Addus HomeCare by 111.9% in the fourth quarter. Natixis now owns 250 shares of the company’s stock valued at $31,000 after purchasing an additional 132 shares during the period. Smartleaf Asset Management LLC lifted its position in shares of Addus HomeCare by 324.2% in the 4th quarter. Smartleaf Asset Management LLC now owns 280 shares of the company’s stock worth $35,000 after buying an additional 214 shares during the last quarter. Parkside Financial Bank & Trust increased its holdings in shares of Addus HomeCare by 38.6% in the 4th quarter. Parkside Financial Bank & Trust now owns 531 shares of the company’s stock worth $67,000 after acquiring an additional 148 shares during the period. Meeder Asset Management Inc. acquired a new stake in shares of Addus HomeCare in the 4th quarter worth about $77,000. Finally, Harvest Fund Management Co. Ltd acquired a new position in Addus HomeCare during the 4th quarter valued at about $86,000. Institutional investors and hedge funds own 95.35% of the company’s stock.

Addus HomeCare Trading Up 1.5%

ADUS opened at $109.90 on Friday. The company’s 50 day moving average is $99.97 and its 200-day moving average is $113.95. The company has a market cap of $2.02 billion, a P/E ratio of 25.15, a PEG ratio of 1.41 and a beta of 0.85. Addus HomeCare Co. has a 1-year low of $88.96 and a 1-year high of $136.72.

Addus HomeCare (NASDAQ:ADUS) last released its quarterly earnings results on Monday, May 5th. The company reported $1.42 earnings per share (EPS) for the quarter, topping the consensus estimate of $1.33 by $0.09. The firm had revenue of $337.71 million during the quarter, compared to analyst estimates of $341.66 million. Addus HomeCare had a net margin of 6.50% and a return on equity of 9.62%. The company’s revenue was up 20.3% compared to the same quarter last year. During the same quarter last year, the business earned $1.21 EPS. On average, equities analysts forecast that Addus HomeCare Co. will post 4.59 EPS for the current year.

Analysts Set New Price Targets

ADUS has been the subject of several recent analyst reports. Stephens reiterated an “overweight” rating and issued a $142.00 target price on shares of Addus HomeCare in a report on Wednesday, March 12th. Oppenheimer increased their price target on shares of Addus HomeCare from $145.00 to $150.00 and gave the stock an “outperform” rating in a research report on Friday, January 24th. Macquarie increased their price target on shares of Addus HomeCare from $129.00 to $133.00 and gave the stock an “outperform” rating in a research note on Thursday, May 8th. StockNews.com lowered shares of Addus HomeCare from a “buy” rating to a “hold” rating in a research note on Wednesday, February 26th. Finally, JMP Securities reiterated a “market outperform” rating and issued a $150.00 target price on shares of Addus HomeCare in a research note on Tuesday, April 22nd. One analyst has rated the stock with a hold rating, six have issued a buy rating and two have assigned a strong buy rating to the stock. Based on data from MarketBeat.com, Addus HomeCare currently has an average rating of “Buy” and a consensus target price of $142.57.

About Addus HomeCare

Addus HomeCare Corporation, together with its subsidiaries, provides personal care services to elderly, chronically ill, disabled persons, and individuals who are at risk of hospitalization or institutionalization in the United States. The company operates through three segments: Personal Care, Hospice, and Home Health.